Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo-Reference-Cited by-同舟云学术

Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo

Published:2021-01-19 Issue:3 Volume:45 Page:987-996
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Xie Shufang¹,Fan Weimin²,Yang Chen²,Lei Wen³,Pan Hongying⁴,Tong Xiangmin²,Wu Yi⁵,Wang Shibing²^ORCID

Affiliation:

1. The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310000, P.R. China

2. Molecular Diagnosis Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China

3. Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, P.R. China

4. Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China

5. Department of Hematology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy;Cancers;2024-09-12

2. Oncolytic Myxoma virus Increases Autophagy in Multiple Myeloma;Turkish Journal of Hematology;2024-03-04

3. Oncolytic virotherapy: basic principles, recent advances and future directions;Signal Transduction and Targeted Therapy;2023-04-11

4. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response;Frontiers in Cellular and Infection Microbiology;2023-03-15

5. Oncolytic viruses in hematological malignancies: hijacking disease biology and fostering new promises for immune and cell-based therapies;Viral Vectors in Cancer Immunotherapy;2023